BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu J, Hu L, Wu F, Zou L, He T. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis. Oncotarget 2017;8:32332-44. [PMID: 28415659 DOI: 10.18632/oncotarget.15974] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Shu G, Hao J, Li W, Zhang L, Qiu Y, Yang X. Liensinine suppresses STAT3-dependent HK2 expression through elevating SHP-1 to induce apoptosis in hepatocellular carcinoma cells in vitro and in vivo. Journal of Functional Foods 2018;45:288-97. [DOI: 10.1016/j.jff.2018.04.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Dong P, Xiong Y, Konno Y, Ihira K, Kobayashi N, Yue J, Watari H. Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway. J Exp Clin Cancer Res 2021;40:216. [PMID: 34174908 DOI: 10.1186/s13046-021-02018-1] [Reference Citation Analysis]
3 Giatromanolaki A, Balaska K, Kalamida D, Kakouratos C, Sivridis E, Koukourakis MI. Thermogenic protein UCP1 and UCP3 expression in non-small cell lung cancer: relation with glycolysis and anaerobic metabolism. Cancer Biol Med 2017;14:396-404. [PMID: 29372106 DOI: 10.20892/j.issn.2095-3941.2017.0089] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mobet Y, Liu X, Liu T, Yu J, Yi P. Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer. Front Cell Dev Biol 2022;10:813581. [DOI: 10.3389/fcell.2022.813581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wu X, Chen J, Liu C, Wang X, Zhou H, Mai K, He G. Slc38a9 Deficiency Induces Apoptosis and Metabolic Dysregulation and Leads to Premature Death in Zebrafish. Int J Mol Sci 2022;23:4200. [PMID: 35457018 DOI: 10.3390/ijms23084200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu T, Ye P, Ye Y, Han B. MicroRNA-216b targets HK2 to potentiate autophagy and apoptosis of breast cancer cells via the mTOR signaling pathway. Int J Biol Sci 2021;17:2970-83. [PMID: 34345220 DOI: 10.7150/ijbs.48933] [Reference Citation Analysis]
7 Ciscato F, Ferrone L, Masgras I, Laquatra C, Rasola A. Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters. Int J Mol Sci 2021;22:4716. [PMID: 33946854 DOI: 10.3390/ijms22094716] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Guo HW, Yuan TZ, Chen JX, Zheng Y. Prognostic value of pretreatment albumin/globulin ratio in digestive system cancers: A meta-analysis. PLoS One 2018;13:e0189839. [PMID: 29300750 DOI: 10.1371/journal.pone.0189839] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
9 Sapir G, Harris T, Uppala S, Nardi-Schreiber A, Sosna J, Gomori JM, Katz-Brull R. [13C6,D8]2-deoxyglucose phosphorylation by hexokinase shows selectivity for the β-anomer. Sci Rep 2019;9:19683. [PMID: 31873121 DOI: 10.1038/s41598-019-56063-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
10 Sobanski T, Rose M, Suraweera A, O'Byrne K, Richard DJ, Bolderson E. Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy. Front Cell Dev Biol 2021;9:633305. [PMID: 33834022 DOI: 10.3389/fcell.2021.633305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Guo Y, Liang F, Zhao F, Zhao J. Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer. Mol Cell Biochem 2020;466:103-15. [PMID: 32006291 DOI: 10.1007/s11010-020-03692-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
12 De Oliveira T, Goldhardt T, Edelmann M, Rogge T, Rauch K, Kyuchukov ND, Menck K, Bleckman A, Kalucka J, Khan S, Gaedcke J, Haubrock M, Beissbarth T, Bohnenberger H, Planque M, Fendt SM, Ackermann L, Ghadimi M, Conradi LC. Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo. Cancers (Basel) 2021;13:1011. [PMID: 33671096 DOI: 10.3390/cancers13051011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Shiah SG, Chou ST, Chang JY. MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:5604. [PMID: 34830755 DOI: 10.3390/cancers13225604] [Reference Citation Analysis]
14 Ghanavat M, Shahrouzian M, Deris Zayeri Z, Banihashemi S, Kazemi SM, Saki N. Digging deeper through glucose metabolism and its regulators in cancer and metastasis. Life Sci 2021;264:118603. [PMID: 33091446 DOI: 10.1016/j.lfs.2020.118603] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Samec M, Liskova A, Koklesova L, Samuel SM, Zhai K, Buhrmann C, Varghese E, Abotaleb M, Qaradakhi T, Zulli A, Kello M, Mojzis J, Zubor P, Kwon TK, Shakibaei M, Büsselberg D, Sarria GR, Golubnitschaja O, Kubatka P. Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J 2020;11:377-98. [PMID: 32843908 DOI: 10.1007/s13167-020-00217-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
16 van Genugten EAJ, Weijers JAM, Heskamp S, Kneilling M, van den Heuvel MM, Piet B, Bussink J, Hendriks LEL, Aarntzen EHJG. Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy. Front Oncol 2021;11:786089. [PMID: 35070990 DOI: 10.3389/fonc.2021.786089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liu Y, Zhang Z, Wang J, Chen C, Tang X, Zhu J, Liu J. Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review. Onco Targets Ther 2019;12:1195-204. [PMID: 30863087 DOI: 10.2147/OTT.S189687] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 11.3] [Reference Citation Analysis]
18 Liu J, Meng C, Li C, Tang K, Tang H, Liao J. Deleted in Breast Cancer 1 as a Novel Prognostic Biomarker for Digestive System Cancers: A Meta-Analysis. J Cancer 2019;10:1633-41. [PMID: 31205519 DOI: 10.7150/jca.26935] [Reference Citation Analysis]
19 Addeo M, Di Paola G, Verma HK, Laurino S, Russi S, Zoppoli P, Falco G, Mazzone P. Gastric Cancer Stem Cells: A Glimpse on Metabolic Reprogramming. Front Oncol 2021;11:698394. [PMID: 34249759 DOI: 10.3389/fonc.2021.698394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhou L, Li M, Yu X, Gao F, Li W. Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells. Int J Biol Sci 2019;15:826-37. [PMID: 30906213 DOI: 10.7150/ijbs.31749] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
21 Abe Y, Ikeda S, Kitadate A, Narita K, Kobayashi H, Miura D, Takeuchi M, O’uchi E, O’uchi T, Matsue K. Low hexokinase-2 expression-associated false-negative 18F-FDG PET/CT as a potential prognostic predictor in patients with multiple myeloma. Eur J Nucl Med Mol Imaging 2019;46:1345-50. [DOI: 10.1007/s00259-019-04312-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
22 Yang Z, Tam KY. Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes. Int J Biol Sci 2018;14:204-16. [PMID: 29483838 DOI: 10.7150/ijbs.22955] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
23 Montrose DC, Galluzzi L. Drugging cancer metabolism: Expectations vs. reality. Int Rev Cell Mol Biol 2019;347:1-26. [PMID: 31451211 DOI: 10.1016/bs.ircmb.2019.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
24 Yin X, Choudhury M, Kang JH, Schaefbauer KJ, Jung MY, Andrianifahanana M, Hernandez DM, Leof EB. Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-β. Sci Signal 2019;12:eaax4067. [PMID: 31848318 DOI: 10.1126/scisignal.aax4067] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
25 Passaniti A, Kim MS, Polster BM, Shapiro P. Targeting mitochondrial metabolism for metastatic cancer therapy. Mol Carcinog 2022. [PMID: 35723497 DOI: 10.1002/mc.23436] [Reference Citation Analysis]
26 Zhong Z, Ye Z, He G, Zhang W, Wang J, Huang S. Low expression of A-kinase anchor protein 5 predicts poor prognosis in non-mucin producing stomach adenocarcinoma based on TCGA data. Ann Transl Med 2020;8:115. [PMID: 32175408 DOI: 10.21037/atm.2019.12.98] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Li WC, Huang CH, Hsieh YT, Chen TY, Cheng LH, Chen CY, Liu CJ, Chen HM, Huang CL, Lo JF, Chang KW. Regulatory Role of Hexokinase 2 in Modulating Head and Neck Tumorigenesis. Front Oncol 2020;10:176. [PMID: 32195170 DOI: 10.3389/fonc.2020.00176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
28 Chan TC, Wu WJ, Li WM, Shiao MS, Shiue YL, Li CF. SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma. Theranostics 2020;10:11775-93. [PMID: 33052246 DOI: 10.7150/thno.51655] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
29 Li M, Gao F, Zhao Q, Zuo H, Liu W, Li W. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis. Cell Death Dis 2020;11:381. [PMID: 32424132 DOI: 10.1038/s41419-020-2579-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
30 Ishfaq M, Bashir N, Riaz SK, Manzoor S, Khan JS, Bibi Y, Sami R, Aljahani AH, Alharthy SA, Shahid R. Expression of HK2, PKM2, and PFKM Is Associated with Metastasis and Late Disease Onset in Breast Cancer Patients. Genes 2022;13:549. [DOI: 10.3390/genes13030549] [Reference Citation Analysis]
31 Garcia SN, Guedes RC, Marques MM. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics. Curr Med Chem 2019;26:7285-322. [PMID: 30543165 DOI: 10.2174/0929867326666181213092652] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
32 Dai W, Meng X, Mo S, Xiang W, Xu Y, Zhang L, Wang R, Li Q, Cai G. FOXE1 represses cell proliferation and Warburg effect by inhibiting HK2 in colorectal cancer. Cell Commun Signal 2020;18:7. [PMID: 31918722 DOI: 10.1186/s12964-019-0502-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
33 Karim S, Burzangi AS, Ahmad A, Siddiqui NA, Ibrahim IM, Sharma P, Abualsunun WA, Gabr GA. PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer. Int J Mol Sci 2022;23:2305. [PMID: 35216429 DOI: 10.3390/ijms23042305] [Reference Citation Analysis]
34 El Hassouni B, Granchi C, Vallés-martí A, Supadmanaba IGP, Bononi G, Tuccinardi T, Funel N, Jimenez CR, Peters GJ, Giovannetti E, Minutolo F. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies. Seminars in Cancer Biology 2020;60:238-48. [DOI: 10.1016/j.semcancer.2019.08.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
35 Chen XH, Yu DL, Zhong JT, Zhou SH, Fan J, Lu ZJ. Targeted Inhibition of HK-II Reversed the Warburg Effect to Improve the Radiosensitivity of Laryngeal Carcinoma. Cancer Manag Res 2021;13:8063-76. [PMID: 34737635 DOI: 10.2147/CMAR.S324754] [Reference Citation Analysis]
36 Chavez-Dominguez R, Perez-Medina M, Lopez-Gonzalez JS, Galicia-Velasco M, Aguilar-Cazares D. The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity. Front Oncol 2020;10:578418. [PMID: 33117715 DOI: 10.3389/fonc.2020.578418] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
37 Zhu L, Jia R, Zhang J, Li X, Qin C, Zhao Q. Quantitative Proteomics Analysis Revealed the Potential Role of lncRNA Ftx in Promoting Gastric Cancer Progression. Proteomics Clin Appl 2020;14:e1900053. [PMID: 31709769 DOI: 10.1002/prca.201900053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Mirra P, Nigro C, Prevenzano I, Leone A, Raciti GA, Formisano P, Beguinot F, Miele C. The Destiny of Glucose from a MicroRNA Perspective. Front Endocrinol (Lausanne) 2018;9:46. [PMID: 29535681 DOI: 10.3389/fendo.2018.00046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
39 Monferrer E, Vieco-Martí I, López-Carrasco A, Fariñas F, Abanades S, de la Cruz-Merino L, Noguera R, Álvaro Naranjo T. Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction. Metabolites 2021;11:264. [PMID: 33922558 DOI: 10.3390/metabo11050264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Wang Y, Zhong X, Zhou L, Lu J, Jiang B, Liu C, Guo J. Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review. Front Oncol 2020;10:1466. [PMID: 33042793 DOI: 10.3389/fonc.2020.01466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Yao J, Liu J, Zhao W. By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma. Onco Targets Ther 2018;11:3793-803. [PMID: 30013360 DOI: 10.2147/OTT.S165220] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
42 Li M, Cai O, Yu Y, Tan S. Paeonol inhibits the malignancy of Apatinib-resistant gastric cancer cells via LINC00665/miR-665/MAPK1 axis. Phytomedicine 2021;96:153903. [PMID: 35026514 DOI: 10.1016/j.phymed.2021.153903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]